Psychiatric Times
Vol 43, Issue 7
Vol 43, Issue 6
Vol 43, Issue 5
Vol 43, Issue 4
Vol 43, Issue 3
Vol 43, Issue 2
Vol 43, Issue 1
Vol 42, Issue 12
Vol 42, Issue 11
Vol 42, Issue 10
Vol 42, Issue 9
Vol 42, Issue 8
Vol 42, Issue 7
Vol 42, Issue 6
Vol 42, Issue 5
Vol 42, Issue 4
Vol 42, Issue 3
Vol 42, Issue 2
Vol 42, Issue 1
Vol 41, Issue 12
Vol 41, Issue 11
Vol 41, Issue 10
Vol 41, Issue 9
Vol 41, Issue 8
Vol 41, Issue 7
Vol 41, Issue 6
Vol 41, Issue 5 Addiction Digital Supplement
Vol 41, Issue 5
Vol 41, Issue 4
Vol 41, Issue 3
Advertisement
Advertisement
Trending on Psychiatric Times
1
Postpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us
2
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms
3
Centanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD
4
FAQ: What Clinicians Need to Know About Postpartum Psychosis
5